Document:

Exhibit 10.16

 

 

 

July 29,
2021

 

Briana Benz

		 	 
	 	 	 
	 	 	 

Dear Briana:

 

This letter agreement (this “Agreement”)
is entered into between Briana Benz (“you”) and Tivic Health Systems, Inc., a Delaware corporation (the “Company”).
This Agreement is effective as of the date you sign this Agreement, as indicated below. This Agreement confirms the current terms and
conditions of your employment with the Company. This Agreement supersedes all prior negotiations, representations or agreements between
you and the Company, including any prior employment agreement, understanding or offer letter between you and the Company.

  

1.            Duties
and Scope of Employment.

 

(a)            Position.
For the term of your employment under this Agreement (your “Employment”), the Company agrees to employ you in the exempt
position of Chief Financial Officer. You will report to the Company’s Chief Executive Officer or to such other person as the Company
subsequently may determine. You will be working out of the Company’s office in Newark, California, although you may initially be
permitted to work remotely, as determined by the Company, it also being understood that the Company may require you to perform business
travel to other locations from time to time in connection with the Company’s business. You will perform the duties and have the
responsibilities and authority customarily performed and held by an employee in your position or as otherwise may be assigned or delegated
to you by the Company.

 

(b)            Obligations
to the Company. During the term of your Employment, you will devote your full business efforts and time to the Company. During your
Employment, you agree that you will not engage in any other employment, occupation, consulting or other business activity without the
prior written consent of the Company, nor will you engage in any other activities that conflict with your obligations to the Company.
You shall comply with the Company’s policies and rules, including those policies located in the Company’s Handbook (and applicable
State Supplement), if any, and the Employee Invention Assignment and Confidentiality Agreement (the “Confidentiality Agreement”),
as they may be in effect from time to time during your Employment.

  

(c)            Employment
at Will. Your Employment will be “at will,” meaning that either you or the Company shall be entitled to terminate your
Employment at any time and for any reason, with or without cause. Any contrary representations that may have been made to you shall be
superseded by this Agreement. This Agreement will constitute the full and complete agreement between you and the Company on the “at-will”
nature of your Employment, which may only be changed in an express written agreement signed by you and a duly authorized officer of the
Company. Except as otherwise herein expressly provided for, upon the termination of your employment, you will only be entitled to the
compensation and benefits earned and the reimbursements described in this Agreement for the period preceding the effective date of the
termination.

 

    -1-

     

    

 

(d)            Commencement
Date. Assuming your acceptance of this Agreement, as evidenced by your signature below, your full-time Employment will be deemed to
have commenced on July 16, 2021.

 

2.            Compensation;
Business Expenses.

 

(a)            Base
Wage. In this exempt position, the Company will pay you as compensation for your Employment a base salary at a gross annual rate of
$250,000, pro-rated for any partial year. Your annual base salary will be subject to review and adjustment based upon the Company’s
normal performance review practices. Your base salary will continue to be payable in accordance with the Company’s standard payroll
procedures. The annual base salary specified in this Section 2(a), together with any modifications, is referred to in this Agreement
as “Base Salary.”

 

(b)            Incentive
Compensation. At the discretion of the Board, you will be eligible to earn a discretionary, annual end-of-year incentive bonus in
an amount of up to 25% of your Base Salary. The exact amount of the incentive bonus you may receive will be dependent on the achievement
of Company milestones and profitability, and such other milestones as the Board deems appropriate. Payment of your incentive bonus, if
earned, will be paid to you as soon as practical following the end of the calendar year, contingent upon final financial results from
the prior year and Board approval of meeting performance objectives whether plan or individual, and in any event, within 60 days therefrom.
You will not earn any incentive bonus (including a prorated bonus) if your employment terminates for any reason before December 31,
for the year in question.

 

(c)            Restricted
Stock Purchase Award. In connection with the commencement of your employment, the Company will recommend that the Board of
Directors of the Company (the “Board”) issue to you a Restricted Stock Purchase Award, to acquire 450,000 shares of the
Company’s Common Stock under the Company’s 2017 Equity Incentive Plan (the “Plan”), at a per share
purchase price of $0.001 (the “Shares”) pursuant to a Restricted Stock Purchase Agreement to be entered into
between you and the Company (the “Purchase Agreement”). All of the Shares shall initially be subject to a
repurchase option in favor of the Company (the “Repurchase Option”), which will lapse at the rate of 1/48th per
month, commencing September 1, 2021, subject to, in each instance, your continued employment with the Company. The issuance of
the Shares will be subject to the terms of the Plan and the Purchase Agreement, including but not limited to a “lock-up”
provision, and a right of first refusal in favor of the Company. The Repurchase Option shall lapse as to all of the shares in the
event of a termination of service without cause in connection with or within 12 months following a Change in Control (as defined in
the Plan), as more fully set forth in the Purchase Agreement.

 

(d)            IPO
Bonus. Subject to and contingent upon the Company’s closing of an initial public offering of its Common Stock, pursuant to an
effective Registration Statement on Form S-1 (the “IPO”), the Company shall, as soon as practicable thereafter,
pay to you a one-time bonus in the amount of $100,000 (the “IPO Bonus”); provided, however, that you are then still
employed by the Company on the date of the closing of the IPO.

 

(e)            Business
Expenses. The Company will reimburse you for your necessary and reasonable business expenses incurred in connection with your duties
hereunder upon presentation of an itemized account and appropriate supporting documentation, all in accordance with the Company’s
generally applicable policies currently in effect or to be adopted after the date hereof, as may be amended from time to time.

 

    -2-

     

    

 

3.            Employee
Benefits. You will be entitled to earn three (3) weeks of Paid Time Off (“PTO”) in accordance with the Company’s
PTO policy. You will remain eligible to participate in the employee benefit plans maintained by the Company and generally available to
similarly situated employees of the Company, subject in each case to the generally applicable terms and conditions of the plan in question
and to the determinations of any person or committee administering such plans. These benefits may change from time to time.

  

4.            Termination
of this Agreement; Separation Benefits.

 

(a)            Termination
of this Agreement. This Agreement and your employment with the Company shall terminate under any of the following conditions:
(i) your death; (ii) your Complete Disability; (iii) upon your receipt of written notice from the Company that your
employment is being terminated for Cause; (iv) upon your receipt of written notice from the Company that your employment is
being terminated other than for Cause; (v) upon sixty (60) days’
written notice by you that you are resigning from your employment with the Company; (vi) upon sixty (60) days’ written
notice by you that you are resigning from your employment with the Company for Good Reason.

 

(b)            Separation
Benefits. You will be entitled to receive separation benefits upon termination of employment only as set forth in Section 4(b)(iv) hereof;
provided, however, that in the event you are entitled to any severance pay under a Company-sponsored severance pay plan, any such severance
pay to which you are entitled under such severance pay plan will reduce the amount of severance pay to which you are entitled pursuant
to Section 4(b)(iv) hereof. In all cases, upon termination of employment you will receive in a lump sum payment for all salary,
earned bonus (if any), and unused PTO accrued as of the date of your termination of employment.

 

(i)            Voluntary
Resignation. If you voluntarily elect to terminate your employment with the Company (other than in the event of a termination by you
for Good Reason), you will not be entitled to any separation benefits.

 

(ii)            Termination
for Cause. If the Company or any successor in interest terminates your employment for Cause (as defined below), you will not be entitled
to receive any separation benefits.

  

(iii)            Termination
for Death or Complete Disability. If your employment with the Company is terminated as a result of your death or Complete Disability,
you will not be entitled to receive any separation benefits.

 

(iv)            Involuntary
Termination. Subject to the provisions of Section 4(b)(iv) and Section 5 hereof, if there is an Involuntary Termination
you will be entitled to receive the following:

 

(A)            Severance
Payment. If and to the extent that you have been employed by the Company for more than three (3) months, but less than or equal
to twelve (12) months, the Company will pay you an amount equal to one-twelfth (1/12th) of your Base Salary for three (3) months,
and if and to the extent that you have been employed by the Company for more than twelve (12) months, the Company will pay you an amount
equal to one-twelfth (1/12th) of your Base Salary for six (6) months (such 3-month or 6-month period, as applicable, herein
referred to as the “Severance Period”), payable in accordance with the Company’s standard payroll procedures
over the Severance Period. Notwithstanding the foregoing or anything herein contained to the contrary, if there is an Involuntary Termination
after the date of the closing of the IPO, you will be entitled to receive one-twelfth (1/12th) of your Base Salary for six
(6) months, payable in accordance with the Company’s standard payroll procedures over the Severance Period.

 

    -3-

     

    

 

(B)            Health
Insurance. Provided that you timely elect such coverage, the Company shall pay your group health continuation coverage under the Consolidated
Omnibus Budget Reconciliation Act of 1986 (“COBRA”) during the Severance Period; provided, however, that in the event
that you become eligible for group insurance coverage in connection with new employment, such COBRA premium payments by the Company shall
terminate immediately and, in furtherance thereof, you represent, warrant, covenant and agree to promptly, and in any event, within seven
(7) days therefrom, notify the Company of your new employment and eligibility for group insurance coverage related thereto.

 

(c)            Definitions.

 

(i)            “Cause”
means the occurrence of any of the following: (A) your conviction for, or plea of no contest to, a felony or a crime involving moral
turpitude; (B) your commission of an act of personal dishonesty that is intended to result in your personal enrichment (excluding
inadvertent acts that are promptly cured following notice); (C) a continued material failure or failures by you to perform your lawful
and reasonable duties of employment (including, but not limited to, compliance with material written policies of the Company and material
written agreements with the Company) (but only after the Company has delivered a written demand for performance to you that describes
the basis for the Company’s belief that you have committed material violations and you have not cured within a period of 15 days
following notice); (D) your willful failure (other than due to physical incapacity) to reasonably cooperate with any audit or investigation
by a governmental authority or the Company of the Company’s business or financial conditions or practices that continues after written
notice from the Board and at least fifteen (15) days to cure; (E) it is determined that you have conducted yourself in an unprofessional,
unethical, illegal or fraudulent manner, or have acted in a manner detrimental to the reputation, character or standing of the Company,
or to the financial condition of the Company, including, but not limited to theft or misappropriation of Company’s assets, engaging
in unlawful discriminatory or harassing conduct, working while under the influence of alcohol or illegal drugs, or the filing of false
expense or related reports; (G) a material breach of any of your fiduciary duties to the Company; (H) any willful, material
violation by you of any law or regulation applicable to the business of the Company; or (I) a material breach of any of the covenants,
representations and warranties contained herein.

  

(ii)            “Change
in Control” shall have the meaning as set forth in the Plan; provided, however, that from and after the closing of the IPO,
 “Change in Control” shall have the meaning as set forth in the Company’s equity incentive or other similar plan adopted
in connection with the closing of the IPO, as may be amended from time to time.

  

(iii)            “Complete
Disability” shall mean your inability to perform your duties under this Agreement, whether with or without reasonable
accommodation, by reason of any incapacity, physical or mental, which the Company, based upon medical advice or an opinion provided
by a licensed physician acceptable to the Company, determines to have incapacitated you from satisfactorily performing all of your
usual services for the Company, with or without reasonable accommodation, for a period of at least one hundred eighty (180) days
during any twelve (12) month period (whether or not consecutive). Based upon such medical advice or opinion, the determination of
the Company shall be final and binding and the date such determination is made shall be the date of such Complete Disability for
purposes of this Agreement.

 

(iv)            “Good
Reason” means the occurrence of one or more of the following (through a single action or series of actions) without your written
consent: (A) the assignment to you of any authority, duties or responsibilities or the reduction of your authority, duties or responsibilities,
either of which results in a material diminution in your authority, duties or responsibilities at the Company, unless you are provided
with a comparable position (i.e., a position of equal or greater organizational level, duties, authority and status); (B) a material
reduction by the Company in your Base Salary, other than a one-time reduction that is applicable to substantially all other similarly-situated
executives; or (C) a non-temporary relocation of your principal work location office to a location that increases your one way commute
from your principal residence by more than 50 miles.

 

    -4-

     

    

 

An event or action will not constitute Good Reason
unless (1) you give the Company written notice within 60 days after you know or should know of the initial existence of such event
or action, (2) such event or action is not reversed, remedied or cured, as the case may be, by the Company as soon as possible but
in no event later than 30 days of receiving such written notice from you, and (3) you terminate employment within 60 days following
the end of the cure period.

 

(v)            “Involuntary
Termination” means a termination of your employment by the Company without Cause or you terminate your employment with the Company
for Good Reason.

  

5.            Conditions
to Receipt of Severance or other Benefits Pursuant to this Agreement.

 

(a)            Release
of Claims Agreement. Notwithstanding anything herein contained to the contrary, in order for you to receive any severance or other
benefits pursuant to Section 4(b) of this Agreement (the “Severance Benefits”), you will be required to sign
and not revoke a separation and release of claims agreement in a form reasonably satisfactory to the Company (the “Release”).
In all cases, the Release must become effective and irrevocable no later than the 60th day following your Involuntary Termination (the
 “Release Deadline Date”). If the Release does not become effective and irrevocable by the Release Deadline Date, you
will forfeit any right to the Severance Benefits. In no event will the Severance Benefits be paid or provided until the Release becomes
effective and irrevocable.

  

(b)            Section 409A.

  

(i)            Notwithstanding
anything to the contrary in this Agreement, no Severance Benefits to be paid or provided to you, if any hereunder that, when considered
together with any other severance payments or separation benefits, are considered deferred compensation under Section 409A of the
Internal Revenue Code of 1986, as amended (the “Code”), and the final regulations and any guidance promulgated thereunder
(“Section 409A”) (together, the “Deferred Payments”) will be paid or provided until you have
a “separation from service” within the meaning of Section 409A. Similarly, no Severance Benefits payable to you, if any,
under this Agreement that otherwise would be exempt from Section 409A pursuant to Treasury Regulation Section 1.409A-1(b)(9) will
be payable until you have a “separation from service” within the meaning of Section 409A.

  

(ii)            It
is intended that none of the Severance Benefits will constitute Deferred Payments but rather will be exempt from Section 409A as
a payment that would fall within the “short-term deferral period” as described in Section 5(b)(iii) below or resulting
from an involuntary separation from service as described in Section 5(b)(iv) below. In no event will you have discretion to
determine the taxable year of payment of any Deferred Payment.

 

(iii)            Notwithstanding
anything to the contrary in this Agreement, if you are a “specified employee” within the meaning of Section 409A at the
time of your separation from service (other than due to death), then the Deferred Payments, if any, that are payable within the first
6 months following your separation from service, will become payable on the date 6 months and 1 day following the date of your separation
from service. All subsequent Deferred Payments, if any, will be payable in accordance with the payment schedule applicable to each payment
or benefit. Notwithstanding anything herein to the contrary, in the event of your death following your separation from service, but before
the 6 month anniversary of the separation from service, then any payments delayed in accordance with this paragraph will be payable in
a lump sum as soon as administratively practicable after the date of your death and all other Deferred Payments will be payable in accordance
with the payment schedule applicable to each payment or benefit. Each payment and benefit payable under this Agreement is intended to
constitute a separate payment under Section 1.409A-2(b)(2) of the Treasury Regulations.

 

    -5-

     

    

 

(iv)            Any
amount paid under this Agreement that satisfies the requirements of the “short-term deferral” rule set forth in Section 1.409A-1(b)(4) of
the Treasury Regulations will not constitute Deferred Payments for purposes of this Section 5.

  

(v)            Any
amount paid under this Agreement that qualifies as a payment made as a result of an involuntary separation from service pursuant to Section 1.409A-
1(b)(9)(iii) of the Treasury Regulations that does not exceed the Section 409A Limit will not constitute Deferred Payments for
purposes of this Section 5.

  

(vi)            The
foregoing provisions are intended to comply with or be exempt from the requirements of Section 409A so that none of the Severance
Benefits will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply
or be exempt. You and the Company agree to work together in good faith to consider amendments to this Agreement and to take such reasonable
actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual
payment to you under Section 409A. In no event will the Company reimburse you for any taxes that may be imposed on you as result
of Section 409A.

 

6.            Pre-Employment
Conditions.

  

(a)            Confidentiality
Agreement. Your acceptance of this offer and commencement of employment with the Company is contingent upon the execution, and delivery
to an officer of the Company, of the Confidentiality Agreement, a copy of which is attached hereto as Attachment A for your review
and execution prior to or on July 29, 2021.

  

(b)            Arbitration
Agreement. In the interest of speedy resolution of disputes, new employees are required to enter into a mutual agreement to arbitrate
claims, a copy of which is attached hereto as Attachment B (the “Arbitration Agreement”) for your review and
execution prior to or on July 29, 2021. Entering into the Arbitration Agreement is a condition of your employment with the Company.
As set forth in more detail in the Arbitration Agreement, you and the company agree to submit to mandatory binding arbitration any and
all claims arising out of or related to your employment with the Company and your termination thereof, including but not limited to, claims
for unpaid wages, wrongful termination, torts, stock or stock options or other ownership interest in the Company and/or discrimination
(including harassment) based upon any federal, state or local ordinance, statute, regulation or constitutional provision. THE PARTIES
HEREBY WAIVE ANY RIGHTS THEY MAY HAVE TO TRIAL BY JURY IN REGARD TO SUCH CLAIMS.

 

(c)            Right
to Work. For purposes of federal immigration law, you will be required to provide to the Company documentary evidence of your identity
and eligibility for employment in the United States. Such documentation must be provided to us within three (3) business days of
July 29, 2021, or our employment relationship with you may be terminated.

 

(d)            Verification
of Information. This offer of employment is also contingent upon the successful verification of the information you provided to the
Company during your application process, as well as a general background check performed by the Company to confirm your suitability for
employment. By accepting this offer of employment, you warrant that all information provided by you is true and correct to the best of
your knowledge, you agree to execute any and all documentation necessary for the Company to conduct a background check and you expressly
release the Company from any claim or cause of action arising out of the Company’s verification of such information.

 

    -6-

     

    

 

7.            Successors.

 

(a)            Company’s
Successors. This Agreement shall be binding upon any successor (whether direct or indirect and whether by purchase, lease, merger,
consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets. For all purposes under
this Agreement, the term “Company” shall include any successor to the Company’s business or assets that becomes
bound by this Agreement.

 

(b)            Your
Successors. This Agreement and all of your rights hereunder shall inure to the benefit of, and be enforceable by, your personal or
legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.

 

8.            Miscellaneous.

  

(a)            Notice.
All notices and other communications contemplated under this Agreement shall be in writing and shall be deemed to have been duly given,
made and received (i) when delivered personally; (ii) two (2) days following the day when deposited with a reputable, established
overnight courier service for delivery to the intended addressee, the first of which such delivery shall have been with signature required
from the recipient; (iii) five (5) days following the day when deposited with the United States Postal Service as first class,
registered or certified mail, postage prepaid; and (iv) by confirmed electronic (email) transmission or facsimile. In your case,
mailed notices shall be addressed to you at the home address that you most recently communicated to the Company in writing. In the case
of the Company, mailed notices shall be addressed to its corporate headquarters, and all notices shall be directed to the attention of
the Board.

 

(b)            Modifications
and Waivers. No provision of this Agreement shall be modified, waived or discharged unless the modification, waiver or discharge
is agreed to in writing and signed by you and by an authorized officer of the Company (other than you). No waiver by either party of
any breach of, or of compliance with, any condition or provision of this Agreement by the other party shall be considered a waiver
of any other condition or provision or of the same condition or provision at another time.

 

(c)            Whole
Agreement. No other agreements, representations or understandings (whether oral or written and whether express or implied) which are
not expressly set forth in this Agreement have been made or entered into by either party with respect to the subject matter hereof. This
Agreement, the Inventions Agreement and the Arbitration Agreement contain the entire understanding of the parties with respect to the
subject matter hereof.

  

(d)            Withholding
Taxes. All payments made under this Agreement shall be subject to reduction to reflect taxes or other charges required to be withheld
by law.

  

(e)            Choice
of Law and Severability. This Agreement shall be interpreted in accordance with the laws of the State of California without giving
effect to provisions governing the choice of law. If any provision of this Agreement becomes or is deemed invalid, illegal or unenforceable
in any applicable jurisdiction by reason of the scope, extent or duration of its coverage, then such provision shall be deemed amended
to the minimum extent necessary to conform to applicable law so as to be valid and enforceable or, if such provision cannot be so amended
without materially altering the intention of the parties, then such provision shall be stricken and the remainder of this Agreement shall
continue in full force and effect. If any provision of this Agreement is rendered illegal by any present or future statute, law, ordinance
or regulation (collectively, the “Law”) then that provision shall be curtailed or limited only to the minimum extent
necessary to bring the provision into compliance with the Law. All the other terms and provisions of this Agreement shall continue in
full force and effect without impairment or limitation.

 

    -7-

     

    

 

(f)            No
Assignment. This Agreement and all of your rights and obligations hereunder are personal to you and may not be transferred or assigned
by you at any time.

  

(g)            Interpretation;
Construction. The headings set forth in this Agreement are for convenience of reference only and shall not be used in interpreting
this Agreement. This Agreement has been drafted by legal counsel to the Company, but you acknowledge your understanding that you have
been advised to consult with an attorney prior to executing this Agreement (and by your execution hereof, you acknowledge that you have
so consulted with an attorney of your choice or have knowingly and voluntarily waived such consultation), and the normal rule of
construction to the effect that any ambiguities are to be resolved against the drafting party will not be employed in the interpretation
of this Agreement.

 

(h)            Representations
and Warranties. You represent and warrant that you are not restricted or prohibited, contractually or otherwise, from entering into
and performing each of the terms and covenants contained in this Agreement, and that your execution and performance of this Agreement
will not violate or breach any other agreements between you and any other person or entity. You further represent and warrant that you
will not, during the term hereof, enter into any oral or written agreement in conflict with any of the provisions of this Agreement, the
agreements referenced herein and the Company’s policies.

 

(i)            Return
of Company Property. Upon termination of this Agreement or earlier as requested by the Company, you shall deliver to the Company any
and all equipment, and, at the election of the Company, either deliver or destroy, and certify thereto, any and all drawings, notes, memoranda,
specifications, devices, formulas and documents, together with all copies, extracts and summaries thereof, and any other material containing
or disclosing any third-party information or proprietary information.

  

(j)            Counterparts.
This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic
signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart
so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

  

We are all delighted to be
able to extend you this offer and look forward to working with you. To indicate your acceptance of the Company’s offer, please sign
and date this letter in the space provided below and return it to me, along with a signed and dated original copy of the Confidentiality
Agreement and Arbitration Agreement, on or before July 29, 2021.

  

This Agreement, the Confidentiality
Agreement and Arbitration Agreement shall be executed and returned to the Company on or before 5:00 P.M. PST time on July 29,
2021 and, to the extent that the Company has not received the executed counterpart signature pages thereto on or before such date
and time, this offer shall be deemed withdrawn and shall expire.

 

    -8-

     

    

 

	Very truly yours,	 
	 	 
	Tivic Health Systems, Inc.	 
	 	 
	By:	/s Jennifer Ernst	 
	Name: 	 Jennifer Ernst, Chief Executive Officer	 
	 	 
	ACCEPTED AND AGREED:	 
	 	 
	Briana Benz	 
	 	 
	/s/ Briana Benz	 
	Signature	 
	 	 
	Date:	07/29/2021	 

 

    -9-

     

    

  

ATTACHMENT A

 

EMPLOYEE INVENTION ASSIGNMENT AND

CONFIDENTIALITY AGREEMENT

  

(Attached)

 

    -10-

     

    

 

ATTACHMENT B

  

ARBITRATION AGREEMENT

 

(Attached)

 

    -11-Exhibit 10.17

 

 

Tivic
Health Systems, Inc.

 

2017 EQUITY INCENTIVE PLAN

 

RESTRICTED STOCK PURCHASE AGREEMENT

 

This Restricted Stock Purchase
Agreement (the “Agreement”) is made as of July 30, 2021 (the “Effective Date”), by and between
Tivic Health Systems, Inc., a Delaware corporation (the “Company”), and Briana Benz (“Purchaser”)
pursuant to and in accordance with the Company’s 2017 Equity Incentive Plan (the “Plan”). Capitalized terms not
defined herein shall have the meanings given in the Plan.

 

1.            Sale
of Stock. Subject to the terms and conditions of this Agreement, on the Purchase Date (as defined below) the Company will issue
and sell to Purchaser, and Purchaser agrees to purchase from the Company, 450,000 shares of the Company’s Common Stock (the “Shares”),
at a price of $0.001 per share (the “Per Share Purchase Price”), for an aggregate purchase price of $450.00 (the “Purchase
Price”), all of which shall be payable in cash. The term “Shares” refers to the purchased Shares and all securities
received in replacement of or in connection with the Shares pursuant to stock dividends or splits, all securities received in replacement
of the Shares in a recapitalization, merger, reorganization, exchange or the like, and all new, substituted or additional securities or
other properties to which Purchaser is entitled by reason of Purchaser’s ownership of the Shares.

 

2.            Issuance
of Shares. The purchase and sale of the Shares under this Agreement shall occur at the principal office of the Company simultaneously
with the execution of this Agreement by the parties or on such other date as the Company and Purchaser shall agree (the “Purchase
Date”). On the Purchase Date, the Company shall, subject to the provisions of Section 3(c)(iv) hereof, deliver to
Purchaser a certificate representing the Shares to be purchased by Purchaser (which shall be issued in Purchaser’s name) against
payment of the Purchase Price therefor.

 

3.            Limitations
on Transfer. In addition to any other limitation on transfer created by applicable securities laws, Purchaser shall not
assign, encumber, hypothecate, pledge or otherwise dispose of any interest in the Shares except in compliance with the provisions of
the Plan, this Agreement and applicable securities laws. In addition to the foregoing limitations on transfer, Purchaser shall not
assign, encumber or dispose of any interest in the Shares while the Shares are subject to the Company’s Repurchase Option (as
defined below). After any Shares have been released from such Repurchase Option, Purchaser shall not assign, encumber or dispose of
any interest in the Shares except to the extent permitted
by, and in compliance with, the Plan, applicable laws, and the provisions of this Agreement.

  

(a)            Repurchase
Option. All of the Shares shall initially be Unvested Shares (as defined in Section 10 below), and shall only become Vested
Shares in accordance with the provisions of Section 3(b) hereof. In the event of Purchaser’s Termination of Service with
the Company for any reason (including as a result of Purchaser’s death), with or without cause, the Company, or its assignee(s),
as determined by the Board of Directors of the Company (the “Board”), shall upon the date of such termination (the
 “Termination Date”), have an irrevocable, exclusive option to repurchase all or any portion of the Unvested Shares
held by Purchaser as of the Termination Date at a per share price equal to the Repurchase Option Purchase Price (as defined in Section 10
below) (the “Repurchase Option”). Purchaser hereby acknowledges that the Company has no obligation, either now or
in the future, to repurchase any of the Shares at any time.

 

     

     

    

 

(b)            Vesting
of Shares. The Unvested Shares shall vest and become Vested Shares (as defined in Section 10 below) as follows:

 

(i)            Time-Based
Vesting. The Unvested Shares shall vest and become Vested Shares in a series of forty-eight (48) substantially equal monthly installments
(rounded downward to the nearest whole share) commencing on the Vesting Commencement Date (defined below), and on each monthly anniversary
thereafter, provided that no Termination of Service shall have occurred prior to each such date, so that all of the Shares shall all be
Vested Shares upon the fourth (4th) anniversary of the Vesting Commencement Date. For the purposes of this Agreement, the “Vesting
Commencement Date” shall be August 1, 2021.

 

(ii)            Part-Time
Employment and Leaves of Absence. If the Purchaser commences working on a part-time basis, or fails to commence working on a
full-time basis after being so requested by the Company, then the Company may adjust the vesting schedule set forth in
Subsection (b)(i) above in accordance with the Company’s part-time work policy, or the terms of an agreement between
the Purchaser and the Company pertaining to his or her part-time schedule, or as otherwise determined by the Board in its reasonable
discretion. If the Purchaser goes on a leave of absence, then the Company may adjust the vesting schedule set forth in
Subsection (b)(i) above in accordance with the Company’s leave of absence policy or the terms of such leave. Except
as provided in the preceding sentence, service shall be deemed to continue while the Purchaser is on a bona fide leave of
absence, if (A) such leave was approved by the Company in writing; and (B) continued crediting of service is expressly
required by the terms of such leave or by applicable law (as determined by the Company). Service shall be deemed to terminate when
such leave ends, unless the Purchaser immediately returns to active work.

 

(iii)            Accelerated
Vesting Upon Occurrence of Certain Circumstances.

 

(A)            Notwithstanding
the foregoing, all of the Unvested Shares shall automatically vest and become Vested Shares upon Purchaser’s Involuntary Termination
(as defined in Section 10 below) in connection with, or within twenty-four (24) months following, a Change in Control.

 (B)            In
the event that the Company terminates Purchaser’s employment with the Company other than for Misconduct, at any time following
the first annual anniversary of the closing of the IPO (as hereinafter defined) then, subject to the provisions hereof, the Repurchase
Option shall lapse as to an additional 56,250 Unvested Shares (the “Accelerated Shares”) so that such Accelerated
Shares shall be Vested Shares as of the Termination Date, in addition to any other Shares that are Vested Shares as of such Termination
Date in accordance with the provisions of this Agreement. Notwithstanding the foregoing or anything herein contained to the contrary,
in no event shall the Repurchase Option lapse as to the Accelerated Shares pursuant to this Section 3(b)(iii)(B) unless (x) Purchaser
shall have executed and delivered to the Company a Release (as defined in the offer letter agreement, by and between the Company and
Purchaser, dated as of July 29, 2021 (the “Offer Letter”)); and the Release shall have become effective and irrevocable
by no later than the Release Deadline Date (as defined in the Offer Letter).

 

    -2- 

     

    

 

(c)            Exercise
of Repurchase Option. The Repurchase Option may be exercised by the Company, or its assignee, by written notice (the “Repurchase
Notice”), at any time within twelve (12) months following the Termination Date (the “Purchase Period”) to
Purchaser or Purchaser’s executor and, at the Company’s option, by delivery to Purchaser or Purchaser’s executor of
the Repurchase Notice and payment of the Repurchase Option Purchase Price as provided in Section 3(c)(i) hereof with respect
to the payment and payment schedule for Shares being repurchased (the “Repurchased Shares”). Upon delivery of such
Repurchase Notice and payment of the Repurchase Option Purchase Price, the Company, or its assignee(s), shall become the legal and beneficial
owner of the Repurchased Shares and all rights and interest therein or related thereto, and the Company, or its assignee(s), as the case
may be, shall have the right to transfer to its own name the number of Repurchased Shares being repurchased by the Company, or its assignee,
without further action by Purchaser. Shares repurchased by the Company as herein contemplated shall resume the status of authorized but
unissued shares of Common Stock of the Company.

 

(i)            Payment
of the Repurchase Option Purchase Price. Payment of the Repurchase Option Purchase Price as set forth in the Repurchase Notice(s) shall
be made, at the option of the Company and/or its assignees, as the case may be, by delivering to Purchaser (or Purchaser’s executor)
within ninety (90) days following delivery of a Repurchase Notice, either (A) a cashier’s check for the full amount, or (B) ten
percent (10%) of the Repurchase Option Purchase Price by cashier’s check and a promissory note (“Promissory Note”)
for the balance of the Repurchase Option Purchase Price set forth in the respective Repurchase Notice, which such Promissory Note shall
provide for equal monthly payments of the principal over a period to be agreed upon by the parties. In the event the parties cannot agree
on the terms of such Promissory Note, the balance shall be paid over a five (5) year period commencing not later than sixty (60)
days after the ten percent (10%) down payment has been paid in cash. Any obligor on a Promissory Note shall have the right to prepay at
any time all or any portion of the entire unpaid principal and accrued interest on thirty (30) days’ written notice to Purchaser,
or any holder in due course of the Promissory Note, as the case may be. The Promissory Note shall bear simple interest at the lower of
(x) the fixed rate of four percent (4%) accruing from the date of purchase, or (y) the highest rate permitted under applicable
law. The Promissory Note shall provide for the acceleration of the maturity of the unpaid principal and interest upon default in the payment
of any installment of principal or interest, at the option of the holder of the Promissory Note.

 

(ii)            Assignment
of Repurchase Right. The Board may freely assign the Company’s Repurchase Option, in whole or in part. Any person who accepts
an assignment of the Repurchase Option from the Company shall assume all of the Company’s rights and obligations under Sections 3(a),
(b) and (c).

 

(iii)            Change
in Control. In the event of a Change in Control of the Company, the Repurchase Option
shall be assigned by the Company to any successor of the Company (or the successor’s parent) in connection with such Change in Control,
and shall continue to apply to any Unvested Shares. To the extent that the Repurchase Option remains in effect following such a Change
in Control, it shall apply to the new capital stock or other property received in exchange for the Shares upon consummation of the Change
in Control, but only to the extent the Shares are at the time covered by such right. Appropriate adjustments shall be made to the price
per share payable upon exercise or deemed exercise of the Repurchase Option to reflect the effect of the Change in Control upon the Company’s
capital structure; provided, however, that the aggregate Repurchase Option Purchase Price shall remain the same.

 

    -3- 

     

    

 

(iv)            Escrow.
For purposes of facilitating the enforcement of the provisions of Section 3 hereof, Purchaser agrees, immediately upon receipt of
the certificate(s) for the Shares subject to the Repurchase Option, to deliver such certificate(s), together with an Assignment Separate
from Certificate in the form attached to this Agreement as Exhibit A executed by Purchaser and by Purchaser’s spouse
(if required for transfer), in blank, to the Secretary of the Company, or the Secretary’s designee, to hold such certificate(s) and
Assignment Separate from Certificate in escrow and to take all such actions and to effectuate all such transfers and/or releases as are
in accordance with the terms of this Agreement. Purchaser hereby acknowledges that the Secretary of the Company, or the Secretary’s
designee, is so appointed as the escrow holder with the foregoing authorities as a material inducement to make this Agreement and that
said appointment is coupled with an interest and is accordingly irrevocable. Purchaser agrees that said escrow holder shall not be liable
to any party hereof (or to any other party). The escrow holder may rely upon any letter, notice or other document executed by any signature
purported to be genuine and may resign at any time. Purchaser agrees that if the Secretary of the Company, or the Secretary’s designee,
resigns as escrow holder for any or no reason, the Board shall have the power to appoint a successor to serve as escrow holder pursuant
to the terms of this Agreement.

 

(d)            Right
of First Refusal.

 

(i)            Transfer
Notice. If at any time Purchaser proposes to transfer any Shares to one or more third parties pursuant to an understanding with
such third parties, then Purchaser shall give the Company written notice of Purchaser’s intention to make the transfer (the “Transfer
Notice”), which Transfer Notice shall include (A) a description of the Shares to be transferred (“Offered Shares”),
(B) the identity of the prospective transferee(s) and (C) the consideration and the material terms and conditions upon
which the proposed transfer is to be made. The Transfer Notice shall certify that Purchaser has received a firm offer from the prospective
transferee(s) and in good faith believes a binding agreement for the transfer is obtainable on the terms set forth in the Transfer
Notice. The Transfer Notice shall also include a copy of any written proposal, term sheet or letter of intent or other agreement relating
to the proposed transfer.

 

(ii)            Company’s
Option. The Company shall have an option for a period of ninety (90) days from receipt of the Transfer Notice to elect to purchase
the Offered Shares at the same price and subject to the same material terms and conditions as described in the Transfer Notice. The Company
may exercise this purchase option and purchase all (or a portion of) the Offered Shares by notifying Purchaser in writing before expiration
of the 90-day period as to the number of Offered Shares the Company wishes to purchase. If the Company gives Purchaser notice of its
intent to purchase the Offered Shares, then the Company shall make payment for the Offered Shares by check or wire transfer against delivery
of the Offered Shares to be purchased at the time and place agreed upon by the parties, which shall be no later than one hundred twenty
(120) days after the Company’s receipt of the Transfer Notice, unless the Transfer Notice contemplated a later closing date or
unless the value of the purchase price has not yet been established pursuant to Section 3(d)(iii). If the Company fails to purchase
all, or purchases less than all, of the Offered Shares by exercising the option set forth in this Section 3(d)(ii) within the
period provided, Purchaser shall be entitled to sell the balance of the Offered Shares to the purchaser(s) named in the Transfer
Notice at the price specified in the Transfer Notice or at a higher price and on the terms and conditions set forth in the Transfer Notice.
Such sale or other transfer must be consummated within 60 days from the expiration of the 90-day period commencing on delivery of the
Transfer Notice, and any proposed sale after such 60-day period may be made only by again complying with the procedures set forth in
this Section 3(d).

 

    -4- 

     

    

 

(iii)            Valuation
of Property. If the purchase price specified in the Transfer Notice is payable in property other than cash or evidence of indebtedness,
the Company shall have the right to pay the purchase price in the form of cash equal in amount to the value of such property. If Purchaser
and the Company cannot agree on such cash value within thirty (30) days after the Company’s receipt of the Transfer Notice, the
valuation shall be made by an appraiser of recognized standing selected by Purchaser and the Company or, if they cannot agree on an appraiser
within forty-five (45) days after the Company’s receipt of the Transfer Notice, each shall select an appraiser of recognized standing
and the two appraisers shall designate a third appraiser of recognized standing, whose appraisal shall be determinative of such value.
The cost of such appraisal shall be shared equally by Purchaser and the Company. If the time for the closing of the Company’s purchase
has expired but for the determination of the value of the purchase price offered by the prospective transferee(s), then such closing shall
be held on or prior to the fifth business day after such valuation shall have been made pursuant to this Section 3(b)(iii). In the
event that a party fails to appoint an appraiser within the time contemplated pursuant to this Section 3(b)(iii), the determination
of the appraiser timely appointed by the Company or Purchaser, as the case may be, shall be determinative of the value of the property
in question.

 

(iv)            Permitted
Transfers. The provisions of Section 3(d) of this Agreement shall not apply to any transfer by Purchaser, with or
without consideration, of any Shares (A) to the Immediate Family of Purchaser, or to a custodian, trustee (including a trustee
of a voting trust), executor, or other fiduciary for the benefit of such persons, or to a trust the benefit of Purchaser, or to a
charitable remainder trust, (B) or in connection with any bona fide gift (collectively, the “Permitted
Transferees”); provided that in each case, such Transferee or assignee, prior to the completion of the transfer, shall
have executed written agreements to be bound by and comply with all applicable provisions of this Agreement. Such transferred Shares
shall remain subject to the restrictions of this Agreement, and such Transferee or assignee shall be treated as a
 “Purchaser” for purposes of this Agreement. Notwithstanding the foregoing or anything herein to the contrary, Purchaser
shall not transfer any Shares which are not Vested Shares or to any Person or Entity which, in the determination of the
Company’s Board of Directors, directly or indirectly competes with the Company. Any such transfer shall be void ab
initio.

 

(v)            Right
of First Refusal in Bylaws. Notwithstanding anything in this Section 3 or elsewhere in this Agreement to the contrary, if
at any time following the date hereof, the Company’s Bylaws contain provisions regarding the right of the Company to repurchase
its securities from shareholders then, notwithstanding such provisions, the terms of this Agreement shall govern the rights of the Company
and/or any other party to purchase Shares from Purchaser if and to the extent that there shall be a conflict between the provisions of
this Agreement and the Company’s Bylaws.

 

    -5- 

     

    

 

(e)            Involuntary
Transfer.

 

(i)            Forfeiture
of Unvested Shares and Company’s Right to Purchase Vested Shares upon Involuntary Transfer. In the event, at any time after
the date of this Agreement, of any transfer by operation of law or other involuntary transfer (including divorce or death, but excluding
in the event of death a transfer to a Permitted Transferee) of all or a portion of the Vested or Unvested Shares by the record holder
thereof, (i) all Unvested Shares shall automatically be immediately forfeited to the Company without consideration payable to Purchaser
or any other action required by the Company, and (ii) the Company, or its assignee, as determined by the Board, shall have the right
to purchase all of such Vested Shares transferred by Purchaser. Upon such a transfer, the person acquiring the Vested Shares shall promptly
notify the Secretary of the Company of such transfer. The right to purchase such Vested Shares shall be provided to the Company for a
period of thirty (30) days following receipt by the Company of written notice by the person acquiring the Vested Shares.

 

(ii)            Price
for Involuntary Transfer. With respect to any Vested Shares to be transferred pursuant to Section 3(e)(i), the purchase
price payable by the Company shall be the fair market value thereof as of or about the date upon which the Company (or its assignee)
exercises its rights to purchase such transferred Shares, as determined by the Board in the exercise of its good faith judgment, and
payment therefor shall be made by the Company to the Transferee over sixty (60) months pursuant to and in accordance with the
provisions of Section 3(c)(i)(B) above.

 

(iii)            Assignment.
The Board may assign the Company’s right to purchase any part of the Vested Shares pursuant to Section 3(e) in whole or
in part to any shareholder or shareholders of the Company or other persons or organizations.

 

(f)            Restrictions
Binding on Transferees. All Transferees of Shares or any interest therein will receive and hold such Shares or interest subject
to the provisions of this Agreement. Any sale or transfer of the Shares shall be void unless the provisions of this Agreement are satisfied.

 

(g)            Termination
of Rights. The Right of First Refusal and the Company’s right to repurchase the Shares in the event of an involuntary transfer
pursuant to Section 3(e) shall terminate upon the first sale of the Common Stock, or other securities of the Company to the
general public pursuant to an effective Registration Statement.

 

    -6- 

     

    

 

(h)            Market
Stand-Off. In connection with any underwritten public offering by the Company of its equity securities pursuant to an effective
registration statement filed under the Securities Act of 1933, as amended, including the Company’s initial public offering (the
 “IPO”), the Purchaser or a Transferee shall not directly or indirectly sell, make any short sale of, loan, hypothecate,
pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of,
or otherwise dispose of or transfer, or agree to engage in any of the foregoing transactions with respect to, any Shares without the prior
written consent of the Company or its managing underwriter. Such restriction (the “Market Stand-Off”) shall be in effect
for such period of time following the date of the final prospectus for the offering as may be requested by the Company or such underwriter.
In order to enforce the Market Stand-Off, the Company may impose stop-transfer instructions with respect to the Shares until the end of
the applicable stand-off period. The Company’s underwriters shall be beneficiaries of the agreement set forth in this Section 3(h).
This Section 3(h) shall not apply to Shares registered in the public offering under the Securities Act.

  

(i)            Adjustments
to Stock. If, from time to time, during the term of the Repurchase Option
there is any change affecting the Company’s outstanding Common Stock as a class that is effected without the receipt of
consideration by the Company (through merger, consolidation, reorganization, reincorporation, stock dividend, dividend in property
other than cash, stock split, liquidating dividend, combination of shares, change in corporation structure or other transaction not
involving the receipt of consideration by the Company), then any and all new, substituted or additional securities or other property
to which Purchaser is entitled by reason of Purchaser’s ownership of Shares shall be immediately subject to the Repurchase
Option and be included in the word “Shares” for all purposes of the Repurchase Option with the same force and effect as
the shares of the Shares presently subject to the Repurchase Option, but only to the extent the Shares are, at the time, covered by
such Repurchase Option. While the total Option Price shall remain the same after each such event, the Option Price per share of
Shares upon exercise or deemed exercise of the Repurchase Option shall be appropriately adjusted.

 

4.            Parachute
Payments.

 

(a)            If
any payment or benefit Purchaser would receive pursuant to a Change in Control from the Company or otherwise (a “Payment”)
would (i) constitute a “parachute payment” within the meaning of Section 280G of the Internal Revenue Code of 1986,
as amended (the “Code”), and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999
of the Code (the “Excise Tax”), then such Payment shall be reduced to the Reduced Amount. The “Reduced Amount”
shall be either (x) the largest portion of the Payment that would result in no portion of the Payment being subject to the Excise
Tax or (y) the largest portion, up to and including the total, of the Payment, whichever amount, after taking into account all applicable
federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results
in Purchaser’s receipt, on an after-tax basis, of the greater amount of the Payment notwithstanding that all or some portion of
the Payment may be subject to the Excise Tax. If a reduction in payments or benefits constituting “parachute payments” is
necessary so that the Payment equals the Reduced Amount, reduction shall occur in the following order unless Purchaser elects in writing
a different order (provided, however, that such election shall be subject to Company approval if made on or after the date on which the
event that triggers the Payment occurs): reduction of cash payments; cancellation of accelerated vesting of stock awards; reduction of
employee benefits. In the event that acceleration of vesting of stock award compensation is to be reduced, such acceleration of vesting
shall be cancelled in the reverse order of the date of grant of Purchaser’s stock awards unless Purchaser elects in writing a different
order for cancellation.

 

    -7- 

     

    

 

(b)            The
accounting firm engaged by the Company for general audit purposes as of the day prior to the effective date of the Change in Control
shall perform the foregoing calculations. If the accounting firm so engaged by the Company is serving as accountant or auditor for
the individual, entity or group effecting the Change in Control, the Company shall appoint a nationally recognized accounting firm
to make the determinations required hereunder. The Company shall bear all expenses with respect to the determinations by such
accounting firm required to be made hereunder.

  

(c)            The
accounting firm engaged to make the determinations hereunder shall provide its calculations, together with detailed supporting documentation,
to the Company and Purchaser within 15 calendar days after the date on which Purchaser’s right to a Payment is triggered (if requested
at that time by the Company or Purchaser) or such other time as requested by the Company or Purchaser. If the accounting firm determines
that no Excise Tax is payable with respect to a Payment, it shall furnish the Company and Purchaser with an opinion reasonably acceptable
to Purchaser that no Excise Tax will be imposed with respect to such Payment. Any good faith determinations of the accounting firm made
hereunder shall be final, binding and conclusive upon the Company and Purchaser.

 

5.            Investment
Representations. As an inducement to the Company to issue the Shares to Purchaser, and in order to establish the suitability for
Purchaser of such an investment, Purchaser hereby makes the following representations and warranties, and authorizes the Company to rely
upon the same:

 

(a)            Investment
Intent. Purchaser is aware of and familiar with the Company’s business affairs and financial condition and has acquired
sufficient information about the Company to reach a knowledgeable and informed decision to acquire the Shares. Purchaser is acquiring
the Shares for investment for his or her own account, not for resale, without any intention of or view toward or for participating, directly
or indirectly, in a distribution of the Shares or any portion thereof.

 

(b)            Representatives.
Purchaser has consulted with such professional advisors (the “Representatives”), if any, as Purchaser has seen fit
in connection with this proposed investment.

 

(c)            Experience.
Purchaser and his or her Representatives, if any, have such knowledge and experience in financial and business matters that Purchaser
is capable of evaluating the merits and risks of his or her receipt of the Shares.

 

(d)            Risks.
Purchaser understands that an investment in the Company is speculative, that any possible profits therefrom are uncertain, and that she
must bear the economic risks of the investment in the Company for an indefinite period of time. Purchaser is able to bear these economic
risks and to hold the Shares for an indefinite period.

 

(e)            Information.
Purchaser and his or her Representatives, if any, have received all information and data with respect to the Company which Purchaser or
his or her Representatives have requested and have deemed relevant in connection with an evaluation of the merits and risks of this investment
in the Company, and do not desire any further information or data with respect to the Company prior to the purchase of the Shares.

 

    -8- 

     

    

 

(f)            Securities
Laws. Purchaser understands that (i) the Shares have not been registered under the Securities Act by reason of a specific
exemption therefrom, that the Shares must be held by Purchaser indefinitely, and that Purchaser must, therefore, bear the economic risk
of such investment indefinitely, unless a subsequent disposition thereof is registered under the Securities Act or is exempt from such
registration. Purchaser further understands that the Shares have not been registered under the “blue sky” laws of any state,
including that the shares have not been qualified or a permit obtained for issuance of securities from the California Department of Corporations
or any other agency of the State of California or any other state.

 

(g)            Transfers.
Purchaser understands that the Shares may have to be held indefinitely unless they are subsequently registered under the Securities Act
and qualified or registered under other applicable securities laws, rules and regulations, which is highly unlikely, or unless an
exemption from such qualification or registration is available.

 

(h)            Legends.
Purchaser understand and agrees that (i) the legends set forth in Section 6 will be placed on the certificate(s) evidencing
the Shares and on certificate(s) issued to Transferees; (ii) the stock records of the Company will be noted with respect to
such restrictions; (iii) the Company will not be under any obligation to register the Shares or to comply with any exemption available
for sale of the Shares without registration; and (iv) the information or conditions necessary to permit routine sales of securities
of the Company under Rule 144 of the Securities Act are not now available and it is not likely that they will become available.

 

(i)            Further
Limitations on Disposition. Subject to the transfer restrictions set forth in this Agreement, without in any way limiting
Purchaser’s representations set forth above, Purchaser further agrees that Purchaser shall in no event make any disposition of
all or any portion of the Shares unless and until: (A)  There is then in effect a Registration Statement under the
Securities Act covering such proposed disposition and such disposition is made in accordance with said Registration Statement; or,
(B) (1) Purchaser shall have notified the Company of the proposed disposition and shall have furnished the Company with a
detailed statement of the circumstances surrounding the proposed disposition, (2) Purchaser shall have furnished the Company
with an opinion of Purchaser’s counsel to the effect that such disposition will not require registration of such shares under
the Securities Act, and (3) such opinion of Purchaser’s counsel shall have been reasonably concurred in by counsel for
the Company and the Company shall have advised Purchaser of such concurrence.

 

(j)            No
Tax Advice; Valuation of Shares. Purchaser understands that Purchaser may suffer adverse tax consequences as a result of Purchaser’s
purchase or disposition of the Shares. In furtherance and not in limitation of the foregoing, the Purchaser acknowledges and agrees that
the Board of Directors of the Company has determined that the fair market value of the Company’s Common Stock is $0.001 per share,
and that the Company believes this valuation represents a fair attempt at reaching an accurate appraisal of their worth. Purchaser understands,
however, that the Company can give no assurances that $0.001 is in fact the fair market value per share of the Shares and that it is possible
that the Internal Revenue Service could successfully assert that the value of the Shares on the date of purchase is greater than so determined.
Purchaser represents that Purchaser has consulted any tax consultants Purchaser deems advisable in connection with the purchase or disposition
of the Shares and that Purchaser is not relying on the Company or the Company’s counsel for any tax advice.

  

    -9- 

     

    

 

6.            Restrictive
Legends and Stop-Transfer Orders.

 

(a)            Legends.
The certificate or certificates representing the Shares shall bear the following legends (as well as any legends required by applicable
state and federal corporate and securities laws):

 

(i)            “THE
SHARES REPRESENTED HEREBY MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, ENCUMBERED OR IN ANY MANNER DISPOSED OF, EXCEPT IN COMPLIANCE
WITH THE TERMS OF A WRITTEN AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED HOLDER OF THE SHARES (OR THE PREDECESSOR IN INTEREST TO
THE SHARES). SUCH AGREEMENT GRANTS TO THE COMPANY CERTAIN RIGHTS OF FIRST REFUSAL UPON AN ATTEMPTED TRANSFER OF THE SHARES AND CERTAIN
REPURCHASE RIGHTS UPON TERMINATION OF SERVICE WITH THE COMPANY. THE SECRETARY OF THE COMPANY WILL UPON WRITTEN REQUEST FURNISH A COPY
OF SUCH AGREEMENT TO THE HOLDER HEREOF WITHOUT CHARGE.”

 

(ii)            “THE
SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR
OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND
ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.”

 

(iii)            Any
legend required to be placed thereon by the state law requirements of any state in the United States.

 

(b)            Stop-Transfer
Notices. Purchaser agrees that, in order to ensure compliance with the restrictions referred to herein, the Company may issue
appropriate “stop transfer” instructions to its transfer agent, if any, and that, if the Company transfers its own securities,
it may make appropriate notations to the same effect in its own records.

 

(c)            Refusal
to Transfer. The Company shall not be required (i) to transfer on its books any Shares that have been sold or otherwise transferred
in violation of any of the provisions of this Agreement or (ii) to treat as owner of such Shares or to accord the right to vote or
pay dividends to any Purchaser or other Transferee to whom such Shares shall have been so transferred.

 

    -10- 

     

    

 

(d)            Removal
of Legend. When all of the following events have occurred, the Shares then held by Purchaser will no longer be subject to the
legend referred to in Section 6(a)(i): (i) the termination of the Right of First Refusal; (ii) the termination of the Repurchase
Option, and (iii) the expiration or termination of the market standoff provisions of Section 3(h) (and of any agreement
entered pursuant to Section 3(h)). After such time, and upon Purchaser’s request, a new certificate or certificates representing
the Shares not repurchased shall be issued without the legend referred to in Section 6(a)(i), and delivered to Purchaser.

 

7.            No
Employment Rights. Nothing in this Agreement shall affect in any manner whatsoever the right or power of the Company, or a parent
or subsidiary of the Company, to terminate Purchaser’s employment or consulting relationship, for any reason, with or without cause.

 

8.            Rights
as Shareholder. With respect to the Shares, (i) Purchaser shall have the same rights as a holder of shares of the Company’s
Common Stock, and (ii) Purchaser shall be entitled to the same dividends paid or declared on the Company’s Common Stock; provided,
however, that such dividend rights shall apply on Shares that are then Vested Shares as of the date upon which such dividends are
declared, unless otherwise prohibited by applicable law. Upon an exercise of the Repurchase Option or the Right of First Refusal, Purchaser
shall have no further rights as a holder of the Shares, except the right to receive payment for the Shares in accordance with the provisions
of this Agreement, and Purchaser shall promptly surrender the stock certificate(s) evidencing the Shares so purchased to the Company
for transfer or cancellation. In furtherance of, and not in limitation of the foregoing, if the Repurchase Option or Right of First Refusal
is exercised in accordance with Section 3 and the Company makes available the consideration for the Shares in respect thereof, then
the person from whom such Shares are purchased shall no longer have any rights as a holder of the Shares (other than the right to receive
payment of such consideration). Such Shares shall be deemed to have been purchased pursuant to Section 3, whether or not the certificate(s) for
such Shares have been delivered to the Company or the consideration for such Shares has been accepted.

 

9.            Section 83(b) Election.
Purchaser understands that Section 83(a) of the Internal Revenue Code of 1986, as amended (the “Code”),
taxes as ordinary income the difference between the amount paid for the Shares (if any) and the fair market value of the Shares as of
the date any restrictions on the Shares lapse. In this context, “restriction” means the right of the Company to buy
back the Shares pursuant to the Repurchase Option set forth in Section 3 of this Agreement. Purchaser understands that Purchaser
may elect to be taxed at the time the Shares are acquired, rather than when and as the Repurchase Option expires, by filing an election
under Section 83(b) (an “83(b) Election”) of the Code with the Internal Revenue Service within thirty
(30) days from the date of transfer. Purchaser understands that failure to file such an election in a timely manner may result in
adverse tax consequences for Purchaser. Purchaser further understands that an additional copy of such election form should be filed with
his or her federal income tax return for the calendar year in which the date of this Agreement falls. Purchaser acknowledges that the
foregoing is only a summary of the effect of United States federal income taxation with respect to purchase of the Shares hereunder, and
does not purport to be complete. Purchaser further acknowledges that the Company has directed Purchaser to seek independent advice regarding
the applicable provisions of the Code, the income tax laws of any municipality, state or foreign country in which Purchaser may reside,
and the tax consequences of Purchaser’s death.

 

    -11- 

     

    

 

Purchaser further agrees that Purchaser will execute,
file and submit to the Company a copy of the 83(b) Election, attached hereto as Exhibit B.

  

PURCHASER UNDERSTANDS THAT SHE MAY SUFFER
ADVERSE TAX CONSEQUENCES AS A RESULT OF HIS OR HER ACQUISITION OR DISPOSITION OF THE SHARES. PURCHASER REPRESENTS THAT SHE HAS CONSULTED
WITH ANY TAX ADVISER SHE DEEMS ADVISABLE IN CONNECTION WITH THE PURCHASE OR DISPOSITION OF THE SHARES AND THAT PURCHASER IS NOT RELYING
ON THE COMPANY OR COMPANY COUNSEL FOR ANY TAX ADVICE. PURCHASER HEREBY ASSUMES ALL RESPONSIBILITY FOR FILING SUCH ELECTION AND PAYING
ANY TAXES RESULTING FROM SUCH ELECTION OR FROM FAILURE TO FILE THE ELECTION AND PAYING TAXES RESULTING FROM THE LAPSE OF THE REPURCHASE
RESTRICTIONS ON THE UNVESTED SHARES.

 

10.            Miscellaneous.

 

(a)            Definitions.
The following defined terms shall have the meaning as set forth below:

 

(i)            “Change
in Control” shall have the meaning set forth in the Plan; provided, however, that notwithstanding the foregoing or anything
herein contained to the contrary, from and after the date of the consummation of the first sale of the Company’s securities to the
public pursuant to an effective registration statement, “Change in Control” shall have the meaning as set forth in the Company’s
equity incentive or similar plan adopted in connection therewith, as may be amended from time to time.

 

(ii)            “Good
Reason” means the occurrence of one or more of the following (through a single action or series of actions) without
Purchaser’s written consent: (A) the assignment to Purchaser of any authority, duties or responsibilities or the
reduction of Purchaser’s authority, duties or responsibilities, either of which results in a material diminution in
Purchaser’s authority, duties or responsibilities at the Company, unless Purchaser is provided with a comparable position
(i.e., a position of equal or greater organizational level, duties, authority and status); (B) a material reduction by the
Company in Purchaser’s base salary, other than a one-time reduction of 20% or less that is applicable to substantially all
other similarly-situated executives; or (C) a non-temporary relocation of Purchaser’s principal work location office to a
location that increases Purchaser’s one way commute from Purchaser’s principal residence by more than 50 miles.

 

An event or action will not constitute Good Reason
unless (1) Purchaser gives the Company written notice within 60 days after Purchaser knows or should know of the initial existence
of such event or action, (2) such event or action is not reversed, remedied or cured, as the case may be, by the Company as soon
as possible but in no event later than 30 days of receiving such written notice from Purchaser, and (3) Purchaser terminates employment
within 60 days following the end of the cure period.

 

(iii)            “Governmental
Body” means any commission, court, tribunal, magistrate, or other similar recognized organization or body of any federal, state,
county, municipal, local, or foreign government or other similar recognized organization or body exercising similar powers or authority.

 

    -12- 

     

    

 

(iv)            “Involuntary
Termination” shall mean a Termination of Service by reason of:

 

(1)            Purchaser’s
involuntary dismissal or discharge by the Company, or by the acquiring or successor entity (or parent or any subsidiary thereof employing
the Purchaser) for reasons other than Misconduct (as defined below), or

 

(2)            Purchaser’s
voluntary resignation for Good Reason.

 

(v)            “Immediate
Family” shall mean any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law,
son-in-law, daughter-in-law, brother-in-law or sister-in-law and shall include adoptive relationships.

 

(vi)            “Misconduct”
means the occurrence of any of the following: (A) Purchaser’s conviction for, or plea of no contest to, a felony or a crime
involving moral turpitude; (B) Purchaser’s commission of an act of personal dishonesty that is intended to result in Purchaser’s
personal enrichment (excluding inadvertent acts that are promptly cured following notice); (C) a continued material failure or failures
by Purchaser to perform Purchaser’s lawful and reasonable duties of employment (including, but not limited to, compliance with
material written policies of the Company and material written agreements with the Company) (but only after the Company has delivered
a written demand for performance to Purchaser that describes the basis for the Company’s belief that Purchaser has committed material
violations and Purchaser has not cured within a period of 15 days following notice); (D) Purchaser’s willful failure (other
than due to physical incapacity) to reasonably cooperate with any audit or investigation by a governmental authority or the Company of
the Company’s business or financial conditions or practices that continues after written notice from the Board and at least fifteen
(15) days to cure; (E) it is determined that Purchaser has conducted herself in an unprofessional, unethical, illegal or fraudulent
manner, or have acted in a manner detrimental to the reputation, character or standing of the Company, or to the financial condition
of the Company, including, but not limited to theft or misappropriation of Company’s assets, engaging in unlawful discriminatory
or harassing conduct, working while under the influence of alcohol or illegal drugs, or the filing of false expense or related reports;
(G) a material breach of any of Purchaser’s fiduciary duties to the Company; (H) any willful, material violation by Purchaser
of any law or regulation applicable to the business of the Company; or (I) a material breach of any of the covenants, representations
and warranties contained herein or in any other agreement with the Company.

 

(vii)            “Parent”
means any corporation (other than the Company) in an unbroken chain of corporations ending with the Company, if each of the corporations
other than the Company owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other
corporations in such chain.

 

(viii)            “Person”
means any individual or entity, and the heirs, executors, administrators, legal representatives, successors, and assigns of such “Person”
where the context so requires.

 

    -13- 

     

    

 

(ix)            “Repurchase
Option Purchase Price” means a per share price equal to the Per Share Purchase Price, for the Shares that are Unvested Shares
as of such Termination Date (as shall be adjusted for any stock splits, stock dividends and the like).

 

(x)            “Right
of First Refusal” shall mean the Company’s right of first refusal described in Section 3(d).

 

(xi)            “Transferee”
means any person to whom Purchaser has directly or indirectly transferred any Shares.

 

(xii)            “Unvested
Shares” shall mean any Shares which have not become Vested Shares.

 

(xiii)            “Vested
Shares” shall mean the Shares that after the date of this Agreement become Vested Shares, whether through the passage of time
or as a result of the occurrence of the circumstances described in Section 3(b)(ii), as applicable.

 

(b)            Governing
Law; Venue. This Agreement shall be governed by and construed in accordance with the laws of the State of California.

  

(c)            Entire
Agreement; Enforcement of Rights. This Agreement, the Plan and the Exhibits hereto (and the Offer Letter, solely for the purposes
of Section 3(b)(iii)(B) hereof) sets forth the entire agreement and understanding of the parties relating to the subject matter
herein and merges all prior discussions between them. No modification of or amendment to this Agreement, nor any waiver of any rights
under this Agreement, shall be effective unless in writing signed by the parties to this Agreement. The failure by either party to enforce
any rights under this Agreement shall not be construed as a waiver of any rights of such party.

  

(d)            Severability.
The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the
validity or enforceability of the other provisions hereof; provided that if any provision of this Agreement, as applied to any party or
to any circumstance, is adjudged by a Governmental Body, arbitrator, or mediator not to be enforceable in accordance with its terms, the
parties agree that the Governmental Body, arbitrator, or mediator making such determination shall have the power to modify the provision
in a manner consistent with its objectives such that it is enforceable, and/or to delete specific words or phrases, and in its reduced
form, such provision shall then be enforceable and shall be enforced.

  

(e)            Construction.
This Agreement is the result of negotiations between and has been reviewed by each of the parties hereto and their respective counsel,
if any; accordingly, this Agreement shall be deemed to be the product of all of the parties hereto, and no ambiguity shall be construed
in favor of or against any one of the parties hereto.

  

(f)            Notices.
All notices, consents, requests, demands and other communications required or permitted under this Agreement shall be in writing and shall
be deemed to have been duly given, made and received (i) when delivered personally; (ii) two (2) days following the day
when deposited with a reputable, established overnight courier service for delivery to the intended addressee; (iii) five (5) days
following the day when deposited with the United States Postal Service as first class, registered or certified mail, postage prepaid;
and (iv) by electronic (email) transmission or facsimile, provided, however, that such email or facsimile is followed by delivery
thereof in any of the manners set forth on clauses (i) through (iii) hereof, in each case, addressed as set forth below or such
other address as such party may hereafter specify for the purpose by notice to the other parties hereto:

 

    -14- 

     

    

  

	 	if to the Company, to:

  

	 	Tivic Health Systems, Inc.
	 	750 Menlo Ave. Suite 200
	 	Menlo Park, California
94025
	 	Attn: Chief Executive
Officer
	 	Email Address:

 

	 	if to Purchaser, to:

 

	 	Briana Benz	 
	 	 	 
	 	 	 
	 	Facsimile No.:	 	 
	 	Email Address:	 	 

  

(g)            Telecopy
Execution and Delivery. A facsimile, telecopy or other reproduction of this Agreement may be executed by one or more parties hereto
and delivered by such party by facsimile or any similar electronic transmission device pursuant to which the signature of or on behalf
of such party can be seen. Such execution and delivery shall be considered valid, binding and effective for all purposes. At the request
of any party hereto, all parties hereto agree to execute and deliver an original of this Agreement as well as any facsimile, telecopy
or other reproduction hereof.

  

(h)            Counterparts.
This Agreement may be executed in any number of counterparts, each of which when so executed and delivered will be deemed an original,
and all such counterparts together will constitute one and the same instrument.

 

(i)            Successors
and Assigns. The rights and benefits of this Agreement shall inure to the benefit of, and be enforceable by the Company’s
successors and assigns. The rights and obligations of Purchaser under this Agreement may only be assigned with the prior written consent
of the Company.

 

[Signature Page Follows]

 

    -15- 

     

    

 

IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed as of the day and year first above written.

  

	COMPANY:	Tivic Health Systems, Inc.

 

	 	By:	/s/ Jennifer Ernst 
	 	 	Name: Jennifer Ernst
	 	 	Title: Chief Executive
Officer

 

	PURCHASER:  	/s/ Briana Benz 
	 	Briana Benz

 

	 	Social Security Number:	 

 

    -16- 

     

    

 

EXHIBIT A

 

Assignment
Separate From Certificate

  

FOR VALUE RECEIVED and pursuant
to that certain Restricted Stock Purchase Agreement between the undersigned (“Purchaser”) and Tivic Health Systems, Inc.,
a Delaware corporation (“Company”), dated July 30, 2021 (the “Agreement”), Purchaser hereby
sells, assigns and transfers unto the Company _________________________________ (________) shares of the Common Stock of the Company standing
in Purchaser’s name on the Company’s books and represented by Certificate No. _____, and does hereby irrevocably constitute
and appoint ______________________ to transfer said stock on the books of the Company with full power of substitution in the premises.
THIS ASSIGNMENT MAY ONLY BE USED AS AUTHORIZED BY THE AGREEMENT AND THE EXHIBITS THERETO.

 

	Dated:	 	 	 
	 	 
	 	Signature:
	 	 
	 	 
	 	Briana Benz

  

Instruction:
Please do not fill in any blanks other than the signature line. The purpose of this assignment is to enable the Company to exercise its
repurchase option set forth in the Agreement without requiring additional signatures on the part of Purchaser.

 

     

     

    

 

EXHIBIT B

 

 

 

Section 83(b) Election
Form and Instructions

 

 

 

THE ATTACHED FORM IS BEING PROVIDED TO
YOU, THE PURCHASER, SOLELY FOR YOUR CONVENIENCE. THE COMPANY MAKES NO REPRESENTATION OR WARRANTY AS TO ITS ADEQUACY OR APPROPRIATENESS.
ANY DECISION BY YOU TO FILE AN ELECTION PURSUANT TO SECTION 83(b) MUST BE MADE SOLELY IN RELIANCE ON THE ADVICE OF YOUR PERSONAL
TAX ADVISOR(S) AND NOT ON ANY STATEMENT OR REPRESENTATION BY THE COMPANY OR ITS AGENTS.

 

Instructions For Filing Elections

 

Attached is a form of election under Section 83(b) of
the Internal Revenue Code. If you wish to make the election, you should complete, sign and date the election and then proceed as follows:

 

A.            Make
4 copies of the completed election.

 

B.            Mail
the signed original election, and one copy of such election, to the IRS Service Center where you file your federal income tax
and include a return, self-addressed, stamped envelope with the election (the IRS will send you a stamped copy, which is your only
proof that a filing has been made). This should be mailed via certified mail, return receipt requested. This election should be sent
immediately, as you have only 30 days from the date of purchase to make the election; no waivers, late filings or extensions are permitted.
For your convenience, a form of cover letter to the IRS is attached hereto.

 

C.            Deliver
one copy of the completed election to the Company’s chief executive officer for the Company’s files.

 

D.            Attach
one copy of the election to your IRS Personal Income Tax Return (Form 1040) when you file it next year.

 

E.            Attach
one copy of the election to your California income tax return (Form 540) when you file it next year (assuming you file a California
income tax return).

 

F.            Retain
one copy of the election for your personal permanent records.

 

A separate Section 83(b) election is
not required to be filed in California if you file a federal Section 83(b) election.

 

It is your responsibility, not the Company’s,
to make sure that the election is properly mailed to the taxing authorities and attached to your tax return filed next year.

  

Within 30 days
after the date of purchase, this election must be filed with the Internal Revenue Service Center where the Purchaser files his or her
federal income tax returns. The filing should be made by registered or certified mail, return receipt requested. The Purchaser must (a) file
a copy of the completed form with his or her federal tax return for the current tax year and (b) deliver an additional copy to the
Company. 

 

     

     

    

  

Section 83(b) Election

 

This statement is made under Section 83(b) of
the Internal Revenue Code of 1986, as amended, pursuant to Treasury Regulations Section 1.83-2.

 

	(1)	The taxpayer who performed the services is:

 

	 	Name:   	Briana Benz
	 	 	 
		Address:	__________
	 	 	__________

 

Social Security No.: _________________________

 

		(2)	The property with respect to which the election is made is 450,000 shares of Common Stock of Tivic Health
Systems, Inc., a Delaware corporation.

 

		(3)	The property was transferred on July __, 2021.

 

		(4)	The taxable year for which the election is made is the calendar year 2021.

 

		(5)	The property is subject to lapsing forfeiture restrictions pursuant to which the property may be forfeited
back to the issuer without payment of consideration if for any reason taxpayer’s service with the issuer is terminated.

  

		(6)	The fair market value of such property at the time of transfer (determined without regard to any restriction
other than a restriction which by its terms will never lapse) is $0.36 per share of Common Stock.

  

		(7)	The amount paid for such property is $0.001 per share of Common Stock.

 

		(8)	A copy of this statement was furnished to Tivic Health Systems, Inc.

 

(9)            This
statement is executed on _____________, 2021.

 

_________________________________

Briana Benz

 

Within 30 days after the date of purchase,
this election must be filed with the Internal Revenue Service Center where the Purchaser files his or her federal income tax returns.
The filing should be made by registered or certified mail, return receipt requested. The Purchaser must (a) file a copy of the completed
form with his or her federal tax return for the current tax year and (b) deliver an additional copy to the Company.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}]]